Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Markus, Magerl"'
Autor:
Adil Adatia, Markus Magerl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/645d1eea643b4b56a58da55c760f7639
Autor:
Anna Valerieva, Teresa Caballero, Markus Magerl, Joao P. Frade, Paul K. Audhya, Timothy Craig
Publikováno v:
Clinical and Translational Allergy, Vol 14, Iss 9, Pp n/a-n/a (2024)
Abstract Background Hereditary angioedema (HAE) is a rare genetic disorder characterized by unpredictable, debilitating episodes of submucosal and/or subcutaneous tissue swelling, which may be life‐threatening depending on anatomic location. The tw
Externí odkaz:
https://doaj.org/article/16eb12a496914dd2981f2fdef6712048
Autor:
Thomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, Karsten Weller, Annika Gutsche, Marcus Maurer, Markus Magerl
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionLanadelumab is a first-line long-term prophylaxis (LTP) in hereditary angioedema (HAE). Real-life data on its long-term efficacy and safety are limited. It is unknown whether patients using lanadelumab need short-term prophylaxis (STP).Ob
Externí odkaz:
https://doaj.org/article/7536b60b93bf481ea32a454fc35cf1e6
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
IntroductionHereditary angioedema (HAE) is a rare hereditary disease with an estimated prevalence of approximately 1 in 50,000.MethodsAn online survey was performed between January and June 2021 on a total of 99 HAE patients (with 92 of them aged 15
Externí odkaz:
https://doaj.org/article/a853e8244fce4b0d9bcdd9315c9a9291
Autor:
Joan Mendivil, Maral DerSarkissian, Aleena Banerji, Lavanya Diwakar, Constance H. Katelaris, Paul K. Keith, Harold Kim, Gina Lacuesta, Markus Magerl, Charlotte Slade, William B. Smith, Zia Choudhry, Angela Simon, Sujata P. Sarda, Paula J. Busse
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 19, Iss 1, Pp 1-13 (2023)
Abstract Background Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, recurring subcutaneous or submucosal swelling. Without effective therapy, HAE can negatively impact patients’ quality of life. Management of HAE inclu
Externí odkaz:
https://doaj.org/article/78d076dcf6d34c9999fa3966bc528fe7
Autor:
Markus Magerl, Anna Sala‐Cunill, Christina Weber‐Chrysochoou, Susanne Trainotti, Ilaria Mormile, Giuseppe Spadaro
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Hereditary angioedema (HAE) is a rare autosomal dominant disease, with patients often suffering with associated symptoms for many years before receiving a correct diagnosis. The symptoms greatly impact a patient's quality of life (QoL) and i
Externí odkaz:
https://doaj.org/article/787d70489ded4d93bb87a68614a36bd3
Autor:
Lauré M. Fijen, Carolina Vera, Thomas Buttgereit, Hanna Bonnekoh, Marcus Maurer, Markus Magerl, Karsten Weller
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Background The Angioedema Control Test (AECT) is a patient‐reported outcome measure developed and validated for the assessment of disease control in patients with recurrent angioedema. Its sensitivity to change and minimal clinically impor
Externí odkaz:
https://doaj.org/article/e4a1c1f171b74b6b9c1e23c3723499c5
Autor:
Marcus Maurer, Thomas Buttgereit, Markus Magerl, Kathrin Schön, Zsusanna Balla, Henriette Farkas
Publikováno v:
Clinical and Translational Allergy, Vol 13, Iss 9, Pp n/a-n/a (2023)
Abstract Background The coronavirus disease pandemic and its containing measures have caused concerns for patients with hereditary angioedema (HAE) and their treating physicians. Both faced challenges surrounding interaction, and communication had to
Externí odkaz:
https://doaj.org/article/af02a9b6caa94b2c9da42740a4052139
Autor:
Marcus Maurer, Markus Magerl, Emel Aygören-Pürsün, Konrad Bork, Henriette Farkas, Hilary Longhurst, Sorena Kiani‑Alikhan, Laurence Bouillet, Isabelle Boccon-Gibod, Mauro Cancian, Andrea Zanichelli, David Launay
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 18, Iss 1, Pp 1-12 (2022)
Abstract Background Hereditary angioedema (HAE) is characterized by potentially severe and life-threatening attacks of localized swelling. Prophylactic therapies are available, including attenuated androgens. Efficacy of attenuated androgens has not
Externí odkaz:
https://doaj.org/article/5c2ad1d8ea544b7b9d2fa3693dc729cb
Autor:
Thomas Buttgereit, Lauré M. Fijen, Carolina Vera, Karl-Christian Bergmann, Marcus Maurer, Markus Magerl
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Hereditary angiodema with normal C1 inhibitor and unknown mutation (HAE-nC1INH-UNK), an exceedingly rare subtype of HAE, appears to be often diagnosed in patients who do not have this condition, but have mast cell-mediated angioedema. Here, we report
Externí odkaz:
https://doaj.org/article/54b0eab98afc498dbe08935f9624c88b